Financhill
Sell
43

URI Quote, Financials, Valuation and Earnings

Last price:
$628.31
Seasonality move :
12.47%
Day range:
$611.36 - $630.48
52-week range:
$585.27 - $896.98
Dividend yield:
1.06%
P/E ratio:
16.22x
P/S ratio:
2.73x
P/B ratio:
4.76x
Volume:
766.9K
Avg. volume:
715.2K
1-year change:
-12.64%
Market cap:
$41B
Revenue:
$15.3B
EPS (TTM):
$38.72
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $8.5B $9.7B $11.6B $14.3B $15.3B
Revenue Growth (YoY) -8.78% 13.9% 19.82% 23.11% 7.07%
 
Cost of Revenues $5.3B $5.9B $6.6B $8.5B $9.2B
Gross Profit $3.2B $3.9B $5B $5.8B $6.2B
Gross Profit Margin 37.32% 39.66% 42.91% 40.56% 40.08%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $979M $1.2B $1.4B $1.5B $1.6B
Other Inc / (Exp) -$9M -$12M $15M -$9M $11M
Operating Expenses $1.4B $1.6B $1.8B $2B $2.1B
Operating Income $1.8B $2.3B $3.2B $3.9B $4.1B
 
Net Interest Expenses $669M $424M $445M $635M $691M
EBT. Incl. Unusual Items $1.1B $1.8B $2.8B $3.2B $3.4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $249M $460M $697M $787M $813M
Net Income to Company $890M $1.4B $2.1B $2.4B $2.6B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $890M $1.4B $2.1B $2.4B $2.6B
 
Basic EPS (Cont. Ops) $12.24 $19.14 $29.77 $35.40 $38.82
Diluted EPS (Cont. Ops) $12.20 $19.04 $29.65 $35.28 $38.69
Weighted Average Basic Share $72.7M $72.4M $70.7M $68.5M $66.3M
Weighted Average Diluted Share $72.9M $72.8M $71M $68.7M $66.6M
 
EBITDA $3.8B $4.3B $5.5B $6.6B $7B
EBIT $1.8B $2.3B $3.2B $3.8B $4.1B
 
Revenue (Reported) $8.5B $9.7B $11.6B $14.3B $15.3B
Operating Income (Reported) $1.8B $2.3B $3.2B $3.9B $4.1B
Operating Income (Adjusted) $1.8B $2.3B $3.2B $3.8B $4.1B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $2.3B $2.8B $3.3B $3.7B $4.1B
Revenue Growth (YoY) -7.21% 21.81% 18.73% 13.11% 9.84%
 
Cost of Revenues $1.4B $1.6B $1.8B $2.2B $2.5B
Gross Profit $869M $1.2B $1.5B $1.6B $1.6B
Gross Profit Margin 38.13% 41.82% 45.15% 41.9% 40%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $258M $322M $378M $393M $436M
Other Inc / (Exp) -$4M -$9M $3M -$4M $2M
Operating Expenses $353M $415M $464M $495M $551M
Operating Income $516M $746M $1B $1.1B $1.1B
 
Net Interest Expenses $125M $93M $132M $161M $180M
EBT. Incl. Unusual Items $387M $644M $895M $902M $909M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $90M $163M $256M $223M $220M
Net Income to Company $297M $481M $639M $679M $689M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $297M $481M $639M $679M $689M
 
Basic EPS (Cont. Ops) $4.11 $6.63 $9.21 $10.03 $10.49
Diluted EPS (Cont. Ops) $4.09 $6.61 $9.15 $9.98 $10.44
Weighted Average Basic Share $72.2M $72.5M $69.4M $67.6M $65.6M
Weighted Average Diluted Share $72.7M $73.2M $69.9M $68M $66M
 
EBITDA $992M $1.3B $1.6B $1.8B $1.9B
EBIT $512M $737M $1B $1.1B $1.1B
 
Revenue (Reported) $2.3B $2.8B $3.3B $3.7B $4.1B
Operating Income (Reported) $516M $746M $1B $1.1B $1.1B
Operating Income (Adjusted) $512M $737M $1B $1.1B $1.1B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $8.5B $9.7B $11.6B $14.3B $15.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $5.3B $5.9B $6.6B $8.5B $9.2B
Gross Profit $3.2B $3.9B $5B $5.8B $6.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $979M $1.2B $1.4B $1.5B $1.6B
Other Inc / (Exp) -$9M -$12M $15M -$9M $11M
Operating Expenses $1.4B $1.6B $1.8B $2B $2.1B
Operating Income $1.8B $2.3B $3.2B $3.9B $4.1B
 
Net Interest Expenses $669M $424M $445M $635M $691M
EBT. Incl. Unusual Items $1.1B $1.8B $2.8B $3.2B $3.4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $249M $460M $697M $787M $813M
Net Income to Company $890M $1.4B $2.1B $2.4B $2.6B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $890M $1.4B $2.1B $2.4B $2.6B
 
Basic EPS (Cont. Ops) $12.26 $19.12 $29.88 $35.43 $38.84
Diluted EPS (Cont. Ops) $12.22 $19.06 $29.76 $35.32 $38.72
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $3.8B $4.3B $5.5B $6.6B $7B
EBIT $1.8B $2.3B $3.2B $3.8B $4.1B
 
Revenue (Reported) $8.5B $9.7B $11.6B $14.3B $15.3B
Operating Income (Reported) $1.8B $2.3B $3.2B $3.9B $4.1B
Operating Income (Adjusted) $1.8B $2.3B $3.2B $3.8B $4.1B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $9.7B $11.6B $14.3B $15.3B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $5.9B $6.6B $8.5B $9.2B --
Gross Profit $3.9B $5B $5.8B $6.2B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.2B $1.4B $1.5B $1.6B --
Other Inc / (Exp) -$12M $15M -$9M $11M --
Operating Expenses $1.6B $1.8B $2B $2.1B --
Operating Income $2.3B $3.2B $3.9B $4.1B --
 
Net Interest Expenses $424M $445M $635M $691M --
EBT. Incl. Unusual Items $1.8B $2.8B $3.2B $3.4B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $460M $697M $787M $813M --
Net Income to Company $1.4B $2.1B $2.4B $2.6B --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.4B $2.1B $2.4B $2.6B --
 
Basic EPS (Cont. Ops) $19.12 $29.88 $35.43 $38.84 --
Diluted EPS (Cont. Ops) $19.06 $29.76 $35.32 $38.72 --
Weighted Average Basic Share $289.7M $282.8M $273.9M $265.4M --
Weighted Average Diluted Share $291.3M $284M $274.9M $266.3M --
 
EBITDA $4.3B $5.5B $6.6B $7B --
EBIT $2.3B $3.2B $3.8B $4.1B --
 
Revenue (Reported) $9.7B $11.6B $14.3B $15.3B --
Operating Income (Reported) $2.3B $3.2B $3.9B $4.1B --
Operating Income (Adjusted) $2.3B $3.2B $3.8B $4.1B --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $202M $144M $106M $363M $457M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.3B $1.7B $2B $2.2B $2.4B
Inventory $125M $164M $232M $205M $200M
Prepaid Expenses $329M $103M $73M $68M $92M
Other Current Assets $42M $60M $73M $62M $90M
Total Current Assets $2B $2.2B $2.7B $2.9B $3.2B
 
Property Plant And Equipment $10B $12B $14.9B $16B $17.3B
Long-Term Investments -- -- -- -- --
Goodwill $5.2B $5.5B $6B $5.9B $6.9B
Other Intangibles $648M $615M $452M $670M $663M
Other Long-Term Assets $38M $42M $47M $43M $49M
Total Assets $17.9B $20.3B $24.2B $25.6B $28.2B
 
Accounts Payable $466M $816M $1.1B $905M $748M
Accrued Expenses $217M $221M $272M $325M $367M
Current Portion Of Long-Term Debt $704M $906M $161M $1.5B $1.2B
Current Portion Of Capital Lease Obligations $178M $202M $211M $249M $294M
Other Current Liabilities $77M $85M $137M $168M $223M
Total Current Liabilities $1.9B $2.6B $2.4B $3.6B $3.3B
 
Long-Term Debt $9B $8.8B $11.2B $10.1B $12.2B
Capital Leases -- -- -- -- --
Total Liabilities $13.3B $14.3B $17.1B $17.5B $19.5B
 
Common Stock $1M $1M $1M $1M $1M
Other Common Equity Adj -$146M -$171M -$264M -$228M -$405M
Common Equity $4.5B $6B $7.1B $8.1B $8.6B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $4.5B $6B $7.1B $8.1B $8.6B
 
Total Liabilities and Equity $17.9B $20.3B $24.2B $25.6B $28.2B
Cash and Short Terms $202M $144M $106M $363M $457M
Total Debt $9.7B $9.7B $11.4B $11.5B $13.4B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $202M $144M $106M $363M $457M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.3B $1.7B $2B $2.2B $2.4B
Inventory $125M $164M $232M $205M $200M
Prepaid Expenses $329M $103M $73M $68M $92M
Other Current Assets $42M $60M $73M $62M $90M
Total Current Assets $2B $2.2B $2.7B $2.9B $3.2B
 
Property Plant And Equipment $10B $12B $14.9B $16B $17.3B
Long-Term Investments -- -- -- -- --
Goodwill $5.2B $5.5B $6B $5.9B $6.9B
Other Intangibles $648M $615M $452M $670M $663M
Other Long-Term Assets $38M $42M $47M $43M $49M
Total Assets $17.9B $20.3B $24.2B $25.6B $28.2B
 
Accounts Payable $466M $816M $1.1B $905M $748M
Accrued Expenses $217M $221M $272M $325M $367M
Current Portion Of Long-Term Debt $704M $906M $161M $1.5B $1.2B
Current Portion Of Capital Lease Obligations $178M $202M $211M $249M $294M
Other Current Liabilities $77M $85M $137M $168M $223M
Total Current Liabilities $1.9B $2.6B $2.4B $3.6B $3.3B
 
Long-Term Debt $9B $8.8B $11.2B $10.1B $12.2B
Capital Leases -- -- -- -- --
Total Liabilities $13.3B $14.3B $17.1B $17.5B $19.5B
 
Common Stock $1M $1M $1M $1M $1M
Other Common Equity Adj -$146M -$171M -$264M -$228M -$405M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $4.5B $6B $7.1B $8.1B $8.6B
 
Total Liabilities and Equity $17.9B $20.3B $24.2B $25.6B $28.2B
Cash and Short Terms $202M $144M $106M $363M $457M
Total Debt $9.7B $9.7B $11.4B $11.5B $13.4B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $890M $1.4B $2.1B $2.4B $2.6B
Depreciation & Amoritzation $2B $2B $2.2B $2.8B $2.9B
Stock-Based Compensation $70M $119M $127M $94M $112M
Change in Accounts Receivable $218M -$300M -$329M -$167M -$20M
Change in Inventories -$5M $9M -$25M $19M $15M
Cash From Operations $2.7B $3.7B $4.4B $4.7B $4.5B
 
Capital Expenditures $1.2B $3.2B $3.7B $4.1B $4.1B
Cash Acquisitions -$2M -$1.4B -$2.3B -$574M -$1.7B
Cash From Investing -$223M -$3.6B -$5B -$3B -$4.1B
 
Dividends Paid (Ex Special Dividend) -- -- -- -$406M -$434M
Special Dividend Paid
Long-Term Debt Issued $9.3B $8.4B $9.9B $8.6B $11.6B
Long-Term Debt Repaid -$11.2B -$8.5B -$8.2B -$8.6B -$9.9B
Repurchase of Common Stock -$286M -$34M -$1.1B -$1.1B -$1.6B
Other Financing Activities -$23M -$8M -$24M -- -$17M
Cash From Financing -$2.3B -$140M $552M -$1.5B -$274M
 
Beginning Cash (CF) $52M $202M $144M $106M $363M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $142M -$62M -$31M $254M $124M
Ending Cash (CF) $202M $144M $106M $363M $457M
 
Levered Free Cash Flow $1.5B $491M $743M $634M $419M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $297M $481M $639M $679M $689M
Depreciation & Amoritzation $480M $532M $577M $697M $762M
Stock-Based Compensation $24M $30M $32M $22M $33M
Change in Accounts Receivable $16M -$76M -$68M $87M $31M
Change in Inventories -$17M $1M $8M -$3M $10M
Cash From Operations $370M $668M $1.3B $1.4B $1B
 
Capital Expenditures $228M $748M $1.1B $725M $683M
Cash Acquisitions -- -$1M -$2B -$168M -$313M
Cash From Investing $63M -$408M -$2.6B -$437M -$515M
 
Dividends Paid (Ex Special Dividend) -- -- -- -$101M -$108M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2B $1.3B $4.7B $1.9B $1.9B
Long-Term Debt Repaid -$2.4B -$1.8B -$3.2B -$2.4B -$1.9B
Repurchase of Common Stock -$5M -$1M -$10M -$264M -$403M
Other Financing Activities -- -- -$15M -- --
Cash From Financing -$412M -$435M $1.4B -$906M -$528M
 
Beginning Cash (CF) $174M $320M $76M $284M $479M
Foreign Exchange Rate Adjustment $7M -$1M -$1M $8M -$27M
Additions / Reductions $21M -$175M $31M $71M $5M
Ending Cash (CF) $202M $144M $106M $363M $457M
 
Levered Free Cash Flow $142M -$80M $199M $689M $365M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $890M $1.4B $2.1B $2.4B $2.6B
Depreciation & Amoritzation $2B $2B $2.2B $2.8B $2.9B
Stock-Based Compensation $70M $119M $127M $94M $112M
Change in Accounts Receivable $218M -$300M -$329M -$167M -$20M
Change in Inventories -$5M $9M -$25M $19M $15M
Cash From Operations $2.7B $3.7B $4.4B $4.7B $4.5B
 
Capital Expenditures $1.2B $3.2B $3.7B $4.1B $4.1B
Cash Acquisitions -$2M -$1.4B -$2.3B -$574M -$1.7B
Cash From Investing -$223M -$3.6B -$5B -$3B -$4.1B
 
Dividends Paid (Ex Special Dividend) -- -- -- -$406M -$434M
Special Dividend Paid
Long-Term Debt Issued $9.3B $8.4B $9.9B $8.6B $11.6B
Long-Term Debt Repaid -$11.2B -$8.5B -$8.2B -$8.6B -$9.9B
Repurchase of Common Stock -$286M -$34M -$1.1B -$1.1B -$1.6B
Other Financing Activities -$23M -- -- -- -$17M
Cash From Financing -$2.3B -$140M $552M -$1.5B -$274M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $142M -$62M -$31M $254M $124M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $1.5B $491M $743M $634M $419M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $1.4B $2.1B $2.4B $2.6B --
Depreciation & Amoritzation $2B $2.2B $2.8B $2.9B --
Stock-Based Compensation $119M $127M $94M $112M --
Change in Accounts Receivable -$300M -$329M -$167M -$20M --
Change in Inventories $9M -$25M $19M $15M --
Cash From Operations $3.7B $4.4B $4.7B $4.5B --
 
Capital Expenditures $3.2B $3.7B $4.1B $4.1B --
Cash Acquisitions -$1.4B -$2.3B -$574M -$1.7B --
Cash From Investing -$3.6B -$5B -$3B -$4.1B --
 
Dividends Paid (Ex Special Dividend) -- -- -$406M -$434M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $8.4B $9.9B $8.6B $11.6B --
Long-Term Debt Repaid -$8.5B -$8.2B -$8.6B -$9.9B --
Repurchase of Common Stock -$34M -$1.1B -$1.1B -$1.6B --
Other Financing Activities -$8M -$24M -- -$17M --
Cash From Financing -$140M $552M -$1.5B -$274M --
 
Beginning Cash (CF) $1.1B $389M $716M $1.7B --
Foreign Exchange Rate Adjustment $4M -$7M $3M -$30M --
Additions / Reductions -$62M -$31M $254M $124M --
Ending Cash (CF) $1.1B $351M $973M $1.8B --
 
Levered Free Cash Flow $491M $743M $634M $419M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk Stock a Buy, Sell or Hold?
Is CyberArk Stock a Buy, Sell or Hold?

CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Is Palantir a Good Stock to Buy?
Is Palantir a Good Stock to Buy?

Palantir Technologies (PLTR) stock soared to its highest level in…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock